Impact of Antifibrotic Treatment on Postoperative Complications in Patients with Interstitial Lung Diseases Undergoing Lung Transplantation: A Systematic Review and Meta-Analysis

Antifibrotic treatment has been approved for reducing disease progression in fibrotic interstitial lung disease (ILD). As a result of increased bleeding risk, some experts suggest cessation of antifibrotics prior to lung transplantation (LT). However, extensive knowledge regarding the impact of anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Taweesedt, Pahnwat, Lertjitbanjong, Ploypin, Eksombatchai, Dararat, Charoenpong, Prangthip, Moua, Teng, Thongprayoon, Charat, Tangpanithandee, Supawit, Petnak, Tananchai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865259/
https://www.ncbi.nlm.nih.gov/pubmed/36675583
http://dx.doi.org/10.3390/jcm12020655

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865259/
https://www.ncbi.nlm.nih.gov/pubmed/36675583
http://dx.doi.org/10.3390/jcm12020655

Ejemplares similares